[1]
HARAHAP, Y., MAGGADANI, B.P., SITORUS, T.R.J., MULYADI, C.A. and PURWANTO, D.J. 2019. CLINICAL APPLICATION OF DRIED BLOOD SPOT FOR MONITORING STUDIES OF TAMOXIFEN, ENDOXIFEN, AND 4-HYDROXYTAMOXIFEN IN BREAST CANCER PATIENT USING LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY. International Journal of Applied Pharmaceutics. 11, 2 (Mar. 2019), 59–63. DOI:https://doi.org/10.22159/ijap.2019v11i2.30310.